| http://dbpedia.org/ontology/abstract
|
Enumeral was a Cambridge, Massachusetts-ba … Enumeral was a Cambridge, Massachusetts-based biotechnology company which developed monoclonal antibody immunotherapies through an 'immunoprofiling' platform that allowed it to scan the human immune microenvironment and identify and validate potential drug candidates. The company filed for Chapter 11 bankruptcy and arranged to sell its assets to Xoma Corporation in January 2018.ssets to Xoma Corporation in January 2018.
|
| http://dbpedia.org/ontology/dissolutionDate
|
"2018-01-29"^^xsd:date
|
| http://dbpedia.org/ontology/fate
|
Assets sold to Xoma Corporation during bankruptcy
|
| http://dbpedia.org/ontology/foundingDate
|
"2009-12-11"^^xsd:date
|
| http://dbpedia.org/ontology/foundingYear
|
2009
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/locationCity
|
http://dbpedia.org/resource/Cambridge%2C_Massachusetts +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
10
|
| http://dbpedia.org/ontology/product
|
http://dbpedia.org/resource/Monoclonal_antibodies +
|
| http://dbpedia.org/ontology/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/ontology/wikiPageID
|
27902882
|
| http://dbpedia.org/ontology/wikiPageLength
|
18562
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1086541738
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Massachusetts_Institute_of_Technology +
, http://dbpedia.org/resource/Whitehead_Institute_for_Biomedical_Research +
, http://dbpedia.org/resource/Nature_%28journal%29 +
, http://dbpedia.org/resource/Harvard_University +
, http://dbpedia.org/resource/Dana%E2%80%93Farber_Cancer_Institute +
, http://dbpedia.org/resource/Massachusetts_General_Hospital +
, http://dbpedia.org/resource/Monoclonal_antibodies +
, http://dbpedia.org/resource/Peripheral_blood_mononuclear_cell +
, http://dbpedia.org/resource/Diabetes_mellitus_type_1 +
, http://dbpedia.org/resource/Intaglio_%28printmaking%29 +
, http://dbpedia.org/resource/Monoclonal_antibody +
, http://dbpedia.org/resource/T_cell +
, http://dbpedia.org/resource/Proinsulin +
, http://dbpedia.org/resource/Merck_&_Co. +
, http://dbpedia.org/resource/Celgene +
, http://dbpedia.org/resource/Chapter_11%2C_Title_11%2C_United_States_Code +
, http://dbpedia.org/resource/Exome +
, http://dbpedia.org/resource/San_Francisco_Bay_Area +
, http://dbpedia.org/resource/Nature_Biotechnology +
, http://dbpedia.org/resource/CD19 +
, http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
, http://dbpedia.org/resource/Small_hairpin_RNA +
, http://dbpedia.org/resource/Nivolumab +
, http://dbpedia.org/resource/Nature_Immunology +
, http://dbpedia.org/resource/Interferon_gamma +
, http://dbpedia.org/resource/OTC_Markets_Group +
, http://dbpedia.org/resource/CEO +
, http://dbpedia.org/resource/Angiogenesis +
, http://dbpedia.org/resource/PD-L1 +
, http://dbpedia.org/resource/Chairman +
, http://dbpedia.org/resource/Chemokine +
, http://dbpedia.org/resource/Immune_checkpoint +
, http://dbpedia.org/resource/Pembrolizumab +
, http://dbpedia.org/resource/Public_company +
, http://dbpedia.org/resource/Bristol-Myers_Squibb +
, http://dbpedia.org/resource/Colorectal_cancer +
, http://dbpedia.org/resource/Reverse_takeover +
, http://dbpedia.org/resource/Cambridge%2C_Massachusetts +
, http://dbpedia.org/resource/Allosteric +
, http://dbpedia.org/resource/PD-1_inhibitor +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Ligand_%28biochemistry%29 +
, http://dbpedia.org/resource/CD8 +
, http://dbpedia.org/resource/CD25 +
, http://dbpedia.org/resource/Cytokine +
|
| http://dbpedia.org/property/defunct
|
"2018-01-29"^^xsd:date
|
| http://dbpedia.org/property/fate
|
Assets sold to Xoma Corporation during bankruptcy
|
| http://dbpedia.org/property/foundation
|
"2009-12-11"^^xsd:date
|
| http://dbpedia.org/property/hqLocationCity
|
http://dbpedia.org/resource/Cambridge%2C_Massachusetts +
|
| http://dbpedia.org/property/hqLocationCountry
|
United States
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Kevin G. Sarney
, John Rydzewski
|
| http://dbpedia.org/property/name
|
Enumeral Biomedical Holdings, Inc.
|
| http://dbpedia.org/property/numEmployees
|
10
|
| http://dbpedia.org/property/products
|
Monoclonal antibodies targeting immune checkpoint proteins
|
| http://dbpedia.org/property/type
|
http://dbpedia.org/resource/Public_company +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Small +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Third-party +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cleanup-PR +
, http://dbpedia.org/resource/Template:For +
, http://dbpedia.org/resource/Template:End_date +
, http://dbpedia.org/resource/Template:Start_date +
, http://dbpedia.org/resource/Template:OTCQB +
, http://dbpedia.org/resource/Template:URL +
, http://dbpedia.org/resource/Template:Multiple_issues +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Rp +
, http://dbpedia.org/resource/Template:Orphan +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Biotechnology_companies_of_the_United_States +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Enumeral?oldid=1086541738&ns=0 +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Enumeral +
|
| http://xmlns.com/foaf/0.1/name
|
Enumeral Biomedical Holdings, Inc.
|
| owl:sameAs |
https://global.dbpedia.org/id/2N432 +
, http://rdf.freebase.com/ns/m.0ck3lp +
, http://www.wikidata.org/entity/Q25111091 +
, http://dbpedia.org/resource/Enumeral +
, http://yago-knowledge.org/resource/Enumeral +
|
| rdf:type |
http://www.wikidata.org/entity/Q43229 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/ontology/Company +
, http://dbpedia.org/ontology/Agent +
, http://www.wikidata.org/entity/Q24229398 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Organisation +
, http://www.wikidata.org/entity/Q4830453 +
|
| rdfs:comment |
Enumeral was a Cambridge, Massachusetts-ba … Enumeral was a Cambridge, Massachusetts-based biotechnology company which developed monoclonal antibody immunotherapies through an 'immunoprofiling' platform that allowed it to scan the human immune microenvironment and identify and validate potential drug candidates. The company filed for Chapter 11 bankruptcy and arranged to sell its assets to Xoma Corporation in January 2018.ssets to Xoma Corporation in January 2018.
|
| rdfs:label |
Enumeral
|
